Congress classified testosterone as a Schedule III controlled substance through the Anabolic Steroids Control Act of 1990. The law took effect in 1991 and brought testosterone and other anabolic steroids under the federal Controlled Substances Act. Before then, anabolic steroids were not federally scheduled substances.
Schedule III recognizes that testosterone has accepted medical uses but can also be misused. Federal law reserves Schedule I for substances with no accepted medical use and a high potential for abuse. Schedule II covers drugs with accepted uses but a high potential for abuse that may cause severe dependence. Schedule III substances have a lower abuse potential than Schedule I or II substances, although misuse may cause moderate physical dependence or high psychological dependence.
Congress acted in response to documented nonmedical steroid use, illicit distribution, and associated health risks. The DEA has cited reproductive harm, liver damage, cardiovascular risks, and psychological dependence among the adverse effects associated with anabolic steroid misuse. Scheduling allowed the federal government to regulate manufacturing, prescribing, dispensing, and distribution without eliminating legitimate medical access.
The Anabolic Steroid Control Act of 2004 broadened the legal definition. A substance can qualify when it is chemically and pharmacologically related to testosterone, unless it falls within specified exclusions such as estrogen, progestins, corticosteroids, or DHEA. The amendment also made it easier for the DEA to add qualifying designer steroids through federal rulemaking.
Schedule III status therefore reflects two findings. Testosterone can serve a legitimate medical purpose, including treatment of male hypogonadism, and unsupervised use creates enough abuse and dependence risk to require controlled prescribing and dispensing.
Schedule III status means a prescriber cannot lawfully issue testosterone merely because a patient requests it. Under 21 CFR 1306.04, a licensed prescriber must issue the prescription for a legitimate medical purpose while acting in the usual course of professional practice. The provider must establish a patient-specific medical basis, document the evaluation, and send a valid controlled-substance prescription to the pharmacy.
FDA-approved TRT treats low testosterone caused by diagnosed hypogonadism. The underlying condition may involve the testicles, pituitary gland, or hypothalamus. The FDA has not approved TRT for age-related testosterone decline alone, and goals such as bodybuilding or general anti-aging do not establish an approved indication.
FDA approval and controlled-substance law address different questions. A clinician may sometimes prescribe an approved drug for an unapproved use, but Schedule III rules still require a legitimate medical purpose and professional evaluation. A seller offering testosterone without a diagnosis or prescription does not meet those requirements.
Federal law sets the minimum standard for every legitimate testosterone prescriber and pharmacy. Texas providers must meet that federal standard along with any additional state requirements governing medical practice, controlled-substance dispensing, and telehealth.
A testosterone prescription requires a diagnostic evaluation rather than one-time approval based on symptoms. Clinicians typically confirm low testosterone with two morning blood tests and review hemoglobin, hematocrit, liver function, luteinizing hormone, prolactin, and prostate-specific antigen when appropriate. These tests help identify hypogonadism, investigate its cause, and screen for conditions that may make treatment unsafe.
Federal rules require prescribers to issue testosterone for a legitimate medical purpose within the usual course of professional practice. Federal law does not impose one universal testing schedule, but that professional-practice standard requires continuing clinical oversight. Providers commonly recheck testosterone around 30 days after treatment begins, assess symptoms after three to six months, and order periodic safety labs while treatment continues.
Schedule III rules also limit refills. A testosterone prescription may receive no more than five refills within six months after its issue date. Once either limit applies, the pharmacy needs a new prescription from the clinician. The clinician may require follow-up testing or another evaluation before issuing it.
Dose selection and injection technique depend on the prescribed formulation and the patient’s response. Optima Tyler’s testosterone cypionate guide covers those treatment details separately.
Texas patients may start or manage TRT through telehealth when the prescriber satisfies federal and state requirements. The Ryan Haight Act generally requires an in-person medical evaluation before a clinician prescribes controlled substances over the internet, subject to defined telemedicine exceptions. Current federal flexibilities permit a DEA-registered practitioner to prescribe Schedule II through V drugs without a prior in-person evaluation when the prescription serves a legitimate medical purpose, the visit uses an approved interactive telecommunications system, and the practitioner follows other prescribing rules.
The current federal flexibility remains effective through December 31, 2026, according to the Center for Connected Health Policy. Separate rules with a December 31, 2025 effective date concern opioid use disorder treatment and certain Veterans Affairs patients. Those narrower rules do not create a general TRT pathway. Federal agencies may extend, replace, or allow the broader temporary policy to expire.
An in-person or hybrid evaluation reduces reliance on a temporary federal exception. A physical visit can establish the required practitioner-patient relationship and allow later follow-ups through telehealth when applicable. However, an in-person visit does not replace laboratory testing, diagnosis, monitoring, or compliance with Texas licensing and prescribing requirements.
Texas tracks testosterone dispensing through its Prescription Monitoring Program. Pharmacies must report Schedule III prescriptions dispensed in Texas, or to Texas residents from out-of-state pharmacies, by the next business day after filling them, according to the Texas State Board of Pharmacy. Testosterone does not appear among the drug classes that always require a prescriber or pharmacist to check the PMP before prescribing or dispensing, but its dispensing record still enters the database.
Optima Tyler explains how online and office visits fit together in its telehealth-versus-in-clinic TRT guide. Because controlled-substance and telemedicine rules can change, confirm current requirements with a licensed Texas provider or pharmacy before relying on a fully online process.
Legitimate TRT starts with a patient-specific diagnosis and continues under licensed clinical supervision. The testosterone molecule may be identical to a product obtained informally, but the dose, medical justification, and oversight differ. A licensed provider uses laboratory results and medical history to determine whether treatment is appropriate, then monitors testosterone levels and relevant health markers.
“No labs, no diagnosis” is a practical warning sign. Sellers that provide testosterone without confirming low levels or evaluating possible contraindications operate outside the normal standard for medical treatment. Unsupervised users may also take doses far above replacement levels, which increases health risks without the monitoring that could identify problems early.
Optima Tyler is LegitScript Certified, which provides an independent trust signal for its online healthcare operations. LegitScript certification does not replace a valid prescription for an individual patient. It also does not replace oversight from a licensed provider or verification by a legitimate dispensing pharmacy.
Gray-market testosterone can expose you to mislabeled strength, contamination, counterfeit products, and dosing errors. Unsupervised use can also worsen elevated red blood cell counts or aggravate conditions that should have been evaluated before treatment. Obtaining or using prescription testosterone outside lawful prescribing and dispensing channels may create legal exposure. Patients should ask a licensed Texas provider or pharmacy about current requirements rather than relying on a seller’s assurances.
Controlled-substance and telemedicine regulations can change as federal and Texas authorities update their rules. The information in this article is educational and does not constitute legal advice. Before pursuing TRT, confirm current prescribing, telehealth, refill, and pharmacy requirements with a licensed Texas provider, pharmacy, or the Texas Medical Board.
Is testosterone a controlled substance federally and in Texas?
Yes. Federal law classifies testosterone as a Schedule III controlled substance, and that classification applies in Texas. The Texas Prescription Monitoring Program collects dispensing records for Schedule III drugs.
Why is testosterone Schedule III rather than a higher schedule?
Testosterone has accepted medical uses, including treatment for diagnosed male hypogonadism. Schedule III reflects its potential for misuse and physical or psychological dependence without treating it like a Schedule I drug with no accepted medical use. Congress placed anabolic steroids in Schedule III under the Anabolic Steroids Control Act of 1990.
Can you get a TRT prescription entirely online in Texas?
Current federal telemedicine flexibilities may permit a qualified, DEA-registered practitioner to prescribe testosterone without an initial in-person evaluation when specific conditions are met. The temporary framework is scheduled to remain effective through December 31, 2026, according to CCHP. Federal and Texas requirements can change, so confirm the current rules with a licensed Texas provider or pharmacy.
How many times can a testosterone prescription be refilled?
Federal rules generally allow up to five refills within six months after the original Schedule III prescription. A prescriber must issue a new prescription after either limit is reached.
What legally separates TRT from steroid misuse?
Legitimate TRT requires a patient-specific prescription issued for a medical purpose by a licensed practitioner. Diagnosis, appropriate dosing, pharmacy dispensing, and continuing monitoring support that purpose. Testosterone obtained without a valid prescription or used for nonmedical performance enhancement may create legal exposure as well as health risks.